全文获取类型
收费全文 | 3950篇 |
免费 | 348篇 |
出版年
2021年 | 52篇 |
2020年 | 48篇 |
2019年 | 38篇 |
2018年 | 60篇 |
2017年 | 55篇 |
2016年 | 101篇 |
2015年 | 165篇 |
2014年 | 209篇 |
2013年 | 222篇 |
2012年 | 286篇 |
2011年 | 287篇 |
2010年 | 200篇 |
2009年 | 157篇 |
2008年 | 259篇 |
2007年 | 232篇 |
2006年 | 214篇 |
2005年 | 173篇 |
2004年 | 163篇 |
2003年 | 158篇 |
2002年 | 143篇 |
2001年 | 86篇 |
2000年 | 73篇 |
1999年 | 74篇 |
1998年 | 50篇 |
1997年 | 38篇 |
1996年 | 53篇 |
1995年 | 40篇 |
1994年 | 34篇 |
1993年 | 27篇 |
1992年 | 37篇 |
1991年 | 48篇 |
1990年 | 37篇 |
1989年 | 33篇 |
1988年 | 21篇 |
1987年 | 31篇 |
1986年 | 23篇 |
1985年 | 23篇 |
1984年 | 15篇 |
1983年 | 17篇 |
1982年 | 17篇 |
1981年 | 17篇 |
1980年 | 15篇 |
1979年 | 16篇 |
1978年 | 14篇 |
1977年 | 15篇 |
1975年 | 14篇 |
1974年 | 25篇 |
1973年 | 24篇 |
1971年 | 15篇 |
1969年 | 15篇 |
排序方式: 共有4298条查询结果,搜索用时 30 毫秒
1.
G Joslin J E Krause A D Hershey S P Adams R J Fallon D H Perlmutter 《The Journal of biological chemistry》1991,266(32):21897-21902
During the formation of an inhibitory complex with neutrophil elastase, alpha 1 antitrypsin (alpha 1 AT) undergoes a structural rearrangement and the resulting alpha 1 AT-elastase complex becomes endowed with chemoattractant activities, mediates an increase in synthesis of alpha 1 AT, and is rapidly cleared from the circulation. In previous studies we have provided evidence that these biological activities involve the recognition of a conformation-specific domain in the alpha 1 AT molecule by a cell surface receptor on human hepatoma HepG2 cells and human monocytes. The receptor has been termed the serpin-enzyme complex (SEC) receptor because it also recognizes complex of serpins antithrombin III, alpha 1 anti-chymotrypsin, and C1 inhibitor with their cognate enzymes. Because a pentapeptide domain of alpha 1 AT (amino acids 370-374, Phe-Val-Phe-Leu-Met) is sufficient for binding to the SEC receptor and the sequence of this domain is remarkably similar to those of substance P, several other tachykinins, bombesin, and the amyloid-beta peptide, we have examined the possibility that these other ligands bind to the SEC receptor. The results indicate that substance P, several other tachykinins, and bombesin compete for binding to, and cross-linking of, the SEC receptor. The SEC receptor is distinct from the substance P receptor by several criteria. There is no substance P receptor mRNA in HepG2 cells; the SEC receptor is present in much higher density on receptor-bearing cells and binds its ligands at lower affinity than the substance P receptor; the SEC receptor is much less restricted in the specificity with which it recognizes ligand; ligands for the SEC receptor including peptide 105Y (based on alpha 1 AT sequence 359-374), alpha 1 AT-protease complexes, and bombesin do not compete for binding of substance P to a stable transfected cell line expressing the substance P receptor. Finally, we show here that the amyloid-beta peptide competes for binding to the SEC receptor but does not bind to the substance P receptor, therein raising the possibility that the SEC receptor is involved in certain biological activities, including the recently described neurotrophic and neurotoxic effects ascribed to the amyloid-beta peptide. 相似文献
2.
3.
T Janatová V Pelouch B Ostádal E G Krause 《Canadian journal of physiology and pharmacology》1986,64(7):897-903
Intra-amnial administration of isoprenaline (IPRO) to chick embryos induces a number of myocardial lesions. The purpose of the present study was to investigate whether similar changes may also be induced after injection of spontaneously oxidized isoprenaline and commercially obtained adrenochrome. Cardiotoxicity of these substances has been demonstrated in adult animals. IPRO, oxidized IPRO, or adrenochrome were administered intra-amnially to 10-day-old chick embryos at doses of 0.1, 1.0, 10.0, and 100.0 mg X kg-1. Parallel experimental groups received propranolol at a dose of 1 mg X kg-1, 15 s before injection of IPRO or oxidized IPRO. The cAMP level in the heart was determined by radioimmunoassay 2 and 30 min after administration of IPRO, oxidized IPRO, or adrenochrome at a single dose of 10.0 mg X kg-1. It has been found that in embryos the effect of IPRO and oxidized IPRO is dose dependent. The rise in mortality and development of cardiomegaly together with increased hydration and disturbances of the development of coronary vascularization were highly significant starting from the dose of 10 mg X kg-1. Furthermore, both drugs significantly increased cAMP levels in the embryonic heart. On the other hand, the administration of adrenochrome was without any effect. The changes induced by IPRO were prevented by the administration of the beta-blocking agent propranolol; the lesions induced by spontaneously oxidized IPRO were, however, prevented only partially. 相似文献
4.
Maria Wilbe Martine Lund Ziener Anita Aronsson Charlotte Harlos Katarina Sundberg Elin Norberg Lisa Andersson Kerstin Lindblad-Toh ?ke Hedhammar G?ran Andersson Frode Lingaas 《PloS one》2010,5(8)
Symmetrical lupoid onychodystrophy (SLO) is an immune-mediated disease in dogs affecting the claws with a suggested autoimmune aethiology. Sequence-based genotyping of the polymorphic exon 2 from DLA-DRB1, -DQA1, and -DQB1 class II loci were performed in a total of 98 SLO Gordon setter cases and 98 healthy controls. A risk haplotype (DRB1*01801/DQA1*00101/DQB1*00802) was present in 53% of cases and 34% of controls and conferred an elevated risk of developing SLO with an odds ratio (OR) of 2.1. When dogs homozygous for the risk haplotype were compared to all dogs not carrying the haplotype the OR was 5.4. However, a stronger protective haplotype (DRB1*02001/DQA1*00401/DQB1*01303, OR = 0.03, 1/OR = 33) was present in 16.8% of controls, but only in a single case (0.5%). The effect of the protective haplotype was clearly stronger than the risk haplotype, since 11.2% of the controls were heterozygous for the risk and protective haplotypes, whereas this combination was absent from cases. When the dogs with the protective haplotype were excluded, an OR of 2.5 was obtained when dogs homozygous for the risk haplotype were compared to those heterozygous for the risk haplotype, suggesting a co-dominant effect of the risk haplotype. In smaller sample sizes of the bearded collie and giant schnauzer breeds we found the same or similar haplotypes, sharing the same DQA1 allele, over-represented among the cases suggesting that the risk is associated primarily with DLA-DQ. We obtained conclusive results that DLA class II is significantly associated with risk of developing SLO in Gordon setters, thus supporting that SLO is an immune-mediated disease. Further studies of SLO in dogs may provide important insight into immune privilege of the nail apparatus and also knowledge about a number of inflammatory disorders of the nail apparatus like lichen planus, psoriasis, alopecia areata and onycholysis. 相似文献
5.
6.
7.
Adipose tissue and cholesterol metabolism 总被引:4,自引:0,他引:4
Adipose tissue in man is a major site for cholesterol storage. In obesity over half of total body cholesterol may reside within this tissue; however, relatively little attention has been directed toward understanding the cholesterol metabolism and its relationship to whole body cholesterol homeostasis in this tissue. In this review the factors which influence cholesterol storage are discussed, with particular emphasis on the effects of diet and drug treatment in both animals and man. The uptake, synthesis, and mobilization of adipose tissue cholesterol appears to be mediated and/or regulated, as in other tissues, by the plasma lipoproteins, and these processes are examined with regard to both normal and pathologic states. 相似文献
8.
9.
W Krause 《Reproducción》1980,4(3):241-246
13 patients with oligozoospermia, showing high prolactin serum levels but no signs of a prolactinoma, were treated with the specific prolactin inhibitor bromocryptine. After a 50 day treatment period an increase of sperm count in 6 cases, a decrease in 2 cases and no alteration in 5 cases was observed. Other semen parameters were not altered. Serum prolactin was significantly lowered. No explanation for the influence of inhibition of prolactin release on spermatogenesis can be given at present. The value of this therapy therefore is doubtful. 相似文献
10.